Figure 3.
(A) The mechanism illustration of gemcitabine re-treatment improving caveolin-1 expression and nab-paclitaxel uptake, and it is further enhanced by encapsulation in MSV to improve targeting ability. Reprinted with the permission from Ref. 82. Copyright © 2017, Elsevier B.V. (B) The effects of CCM-HSA-NPs in HUVEC binding and transcytosis in cells, and the (C) anti-tumor efficacy of CCM-HAS-NPs in xenograft HCT116 (left) and MiaPaCa2 models (right). Reprinted with the permission from Ref. 88. Copyright © 2010 Elsevier B.V.